BALYASNY ASSET MANAGEMENT L.P. - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 174 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$7,112
-81.5%
18,283
-78.8%
0.00%
Q2 2023$38,501
-49.3%
86,228
+77.2%
0.00%
Q4 2022$75,910
-32.8%
48,660
-25.5%
0.00%
Q3 2022$113,000
+15.3%
65,329
+15.7%
0.00%
Q2 2022$98,000
-96.0%
56,484
-83.1%
0.00%
-100.0%
Q1 2020$2,481,000
+929.5%
333,487
+828.9%
0.03%
+1350.0%
Q4 2015$241,00035,9000.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Defender Capital, LLC. 648,800$1,920,0001.55%
Round Table Services, LLC 339,391$998,0000.31%
ARK Investment Management 3,955,017$11,628,0000.29%
Nikko Asset Management Americas, Inc. 4,884,100$14,359,0000.28%
WASATCH ADVISORS LP 6,735,726$19,803,0000.19%
Cedar Brook Financial Partners, LLC 41,500$122,0000.06%
Unified Trust Company, N.A. 15,716$46,0000.03%
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors 13,500$40,0000.03%
STONERIDGE INVESTMENT PARTNERS LLC 16,914$50,0000.02%
Sumitomo Mitsui Trust Holdings, Inc. 4,884,100$14,359,0000.01%
View complete list of INOVIO PHARMACEUTICALS INC shareholders